Global Smart Biopsy Devices Market Set to Achieve $4.05 Billion Milestone with Sustained 7.5% CAGR
The smart biopsy devices market size is expected to see strong growth in the next few years. It will grow to $4.05 billion in 2029 at a compound annual growth rate (CAGR) of 7.5%. The growth in the forecast period can be attributed to personalized medicine growth, advancements in imaging modalities, rise in biopsy for biomarker analysis, market entry of new players, enhanced data connectivity. Major trends in the forecast period include robot-assisted biopsies, ai-driven biopsy assistance, development of wireless biopsy tools, portable and handheld devices, real-time guidance systems.
Get Your Free Sample of The Global Smart Biopsy Devices Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12271&type=smp
How has the smart biopsy devices market evolved, and what factors have shaped its growth?
The rising cancer cases are expected to propel the growth of the smart biopsy devices market going forward. Cancer is a broad category of illnesses that can develop in nearly any organ or tissue in the body when aberrant cells proliferate uncontrollably, cross their usual boundaries, and either spread to other organs or invade neighboring body parts. The rising number of cancer cases increased the need for precise and focused tissue samples. This has sparked the creation and advancement of smart biopsy instruments with better molecular, imaging, and precision capabilities to aid diagnosis and treatment planning. For instance, in January 2024, according to the World Health Organization, a Switzerland-based Intergovernmental organization, it is projected that there will be over 35 million new cancer cases by 2050, marking a 77% increase from the estimated 20 million cases and 9.7 million deaths recorded in 2022. Therefore, the rising cancer cases are driving the growth of the smart biopsy device market.
What are the major segments of the smart biopsy devices market?
The smart biopsy devices market covered in this report is segmented –
1) By Product: Needle-Based Biopsy Instruments, Procedure Trays, Localization Wires, Other Products
2) By Guidance Technique: Ultrasound-Guided Biopsy, Stereotactic-Guided Biopsy, Magnetic Resonance Imaging-Guided Biopsy, Other Guidance Techniques
3) By Application: Breast Cancer, Skin Cancer, Liver Cancer, Prostate Cancer, Other Applications
4) By End-User: Hospitals, Academic And Research Institutes, Diagnostic And Imaging Centers
Subsegments:
1) By Needle-Based Biopsy Instruments: Core Needle Biopsy Devices, Fine Needle Aspiration (FNA) Devices, Vacuum-Assisted Biopsy Devices
2) By Procedure Trays: Pre-Packaged Biopsy Procedure Trays, Customizable Procedure Trays
3) By Localization Wires: Hook Wire Localization Devices, Radar Localization Devices, Magnetic Localization Devices
4) By Other Products: Biopsy Markers, Biopsy Imaging Systems, Biopsy Guidance Systems
Order your report now for swift delivery
https://www.thebusinessresearchcompany.com/report/smart-biopsy-devices-global-market-report
Which companies dominate the smart biopsy devices market?
Major companies operating in the smart biopsy devices market include Cardinal Health Inc, General Electric Company, Medtronic Plc, Danaher Corporation, Canon Medical Systems Corporation, Toshiba Corporation, Siemens Healthineers, FUJIFILM Holdings Corporation, Becton Dickinson and Company, Boston Scientific Corporation, B. Braun Melsungen AG, Olympus Corporation, Intuitive Surgical Inc., Hologic Inc., Cook Medical Inc., CONMED Corporation, Leica Biosystems, Argon Medical Devices Inc., Esaote SpA, SOMATEX Medical Technologies GmbH, Planmed Oy, TSK Laboratory Europe B.V., DTR Medical Ltd., INRAD Inc., Sterylab Srl, EndoMed Systems GmbH
How will evolving trends contribute to the growth of the smart biopsy devices market?
Major companies operating in the smart biopsy device market are innovating advanced products, such as breast biopsy markers, to improve the precision and effectiveness of breast cancer diagnostics. These markers are designed to accurately pinpoint the location of a tissue sample taken during a biopsy, helping to guide future treatments and ensure the correct area is monitored for potential malignancy. For instance, in August 2022, Mammotome, a US-based medical devices company, launched the Mammotome DualCore Dual Stage Core Biopsy System, a minimally invasive breast biopsy device that uses a dual-stage process to provide accurate, high-quality tissue samples. It is often used with ultrasound guidance for precise, safe, and efficient breast cancer diagnosis. This system can be combined with advanced breast biopsy markers to offer clinicians a comprehensive and innovative solution for ultrasound-guided breast biopsies.
What are the key regional dynamics of the smart biopsy devices market, and which region leads in market share?
North America was the largest region in the smart biopsy devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the smart biopsy devices market report during the forecast period. The regions covered in the smart biopsy devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Does The Smart Biopsy Devices Market Report 2025 Offer?
The smart biopsy devices market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Smart biopsy devices refer to intelligent instruments intended to increase the precision and efficiency of tissue samples during medical procedures. It has features such as image guidance, real-time feedback, or robotic help to improve diagnostic capabilities and patient outcomes. It is used for diagnosing cancer and delivering therapeutic drugs.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12271
About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Comments
Post a Comment